IP Verse

Pcv/Mycoplasma Hyopneumoniae/Prrs Combination Vaccine - EP2833909

The patent EP2833909 was granted to Zoetis on Feb 6, 2019. The application was originally filed on Apr 3, 2013 under application number EP13717118A. The patent is currently recorded with a legal status of "Revoked".

EP2833909

ZOETIS
Application Number
EP13717118A
Filing Date
Apr 3, 2013
Status
Revoked
Apr 27, 2024
Grant Date
Feb 6, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM ANIMAL HEALTH USAFeb 7, 2019D YOUNGADMISSIBLE

Patent Citations (45) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2011IB55003
DESCRIPTIONEP0595436
DESCRIPTIONES2074950
DESCRIPTIONGB2282811
DESCRIPTIONUS2011150913
DESCRIPTIONUS5620691
DESCRIPTIONUS5695766
DESCRIPTIONUS5788962
DESCRIPTIONUS6110467
DESCRIPTIONUS6162435
DESCRIPTIONUS6165995
DESCRIPTIONUS6251397
DESCRIPTIONUS6251404
DESCRIPTIONUS6268199
DESCRIPTIONUS6380376
DESCRIPTIONUS6500662
DESCRIPTIONUS6592873
DESCRIPTIONUS6610310
DESCRIPTIONUS6773908
DESCRIPTIONUS6977078
DESCRIPTIONUS7223854
DESCRIPTIONUS7264802
DESCRIPTIONUS7264957
DESCRIPTIONUS7279166
DESCRIPTIONUS7419806
DESCRIPTIONUS7517976
DESCRIPTIONUS7575752
DESCRIPTIONWO03049703
DESCRIPTIONWO9221375
DESCRIPTIONWO9303760
DESCRIPTIONWO9307898
DESCRIPTIONWO9314196
INTERNATIONAL-SEARCH-REPORTWO2007116032
INTERNATIONAL-SEARCH-REPORTWO2009126356
INTERNATIONAL-SEARCH-REPORTWO2011141443
INTERNATIONAL-SEARCH-REPORTWO9628472
OPPOSITIONEP0283840
OPPOSITIONEP2217271
OPPOSITIONEP2327787
OPPOSITIONUS2009317423
OPPOSITIONUS5084269
OPPOSITIONUS8546149
OPPOSITIONUS9687544
OPPOSITIONWO2012025612
OPPOSITIONWO9628472

Non-Patent Literature (NPL) Citations (32) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- ANIMAL et al., "PRRS Seroprevalence on U.S. Swine Operations", Health Inspection Service Info sheet, (20090100), XP055565880
OPPOSITION- Antibody Purification Handbook, Amersham Biosciences, (20020000), page Complete
OPPOSITION- BAUTISTA et al., "Seroprevalence of PRRS virus in the United States", Swine Health and Production, (19930000), vol. 1, pages 4 - 8, XP055566012
OPPOSITION- Boehringer Ingelheim, "Ingelvac CircoFLEX-MycoFLEX Material Safety Data Sheet", (20080623), pages 1 - 10, XP055306404
OPPOSITION- CHEN et al., Veterinary Microbiology, (20000000), vol. 73, pages 301 - 310
OPPOSITION- "Committee for Human Medicinal Products (CHMP) notes for guidance of the clinical evaluation of vaccines", EMEA, (20050517), pages 1 - 23, XP055565795
OPPOSITION- EICHMEYER et al., "Efficacy of Ingelvac® PRRS MLV when rehydrated with a combination of Ingelvac MycoFLEX® and Ingelvac CircoFLEX®", Allen D. Leman Swine Conference, (20100000), page 153, XP055565896
OPPOSITION- "FOR THE EVALUATION OF COMBINATION VACCINES FOR PREVENTABLE DISEASES: PRODUCTION , TESTING AND CLINICAL STUDIES", FDA, (19970400), pages FP - 19, XP055565783
OPPOSITION- HAIWICK et al., "Trivalent vaccine mixture protects against simultaneous challenge with M. hyopneumoniae, PCV2, and PRRS virus", Allen D. Leman Swine Conference, (20100000), page 176, XP055565903
OPPOSITION- KAISER et al., "Mycoplasma hyopneumoniae efficacy and field safety evaluation of a 3-way Haemophilus parasuis/Mycoplasma hyopneumoniae combination bacterin", Conference paper, Allen D. Leman Swine Conference, (20080000), page 31, XP055565848
OPPOSITION- Kenneth Ming-Chih LAM, "Serologic and immunologic studies on Mycoplasma hyopneumoniae pneumonia of swine", Retrospective Theses and Dissertations, (19700000), pages FP - 118, XP055565998
OPPOSITION- KRICKA LJ, "Interferences in Immunoassay - Still a Threat", Clin. Chem., (20000000), vol. 46, no. 8, pages 1037 - 1038, XP055321256
OPPOSITION- Neuberger et al., "Innovation and Technology Contributing to the Development of Fosteraâ„¢PCV MH", Zoetis Technical update, (20131000), pages 1 - 4, XP055565772
OPPOSITION- O'DEA, "Porcine circovirus infection", Australia and New Zealand Standard Diagnostic Procedure, (20100700), XP055565863
OPPOSITION- PIONTKOWSKI et al., "Multi-site field study confirms safety of trivalent vaccine mixture", Allen D. Leman Swine Conference, (20100000), page 177, XP055566019
OPPOSITION- "Porcine Respiratory Disease Complex", The Pig Site, (20090212), URL: https://thepigsite.com/articles/porcine-respiratory-disease-complex, XP055565799
OPPOSITION- QUILITIS et al., "Poster presentation . P235. Serological response to PRRS vaccination using a a mycoplasma bacterin (MYPRAVA SUIS) as diluents for a live attenuated PRRSV vaccine "AMERVAC PRRS"", proceedings of the 21st IPVS Congress, Vancouver , Canada, (20100718), page 541, XP055565857
OPPOSITION- "Responsible use of vaccines and vaccination in pig production", RUMA Guidelines, (20061100), pages 1 - 24, XP055565889
OPPOSITION- RICE et al., G86-797 Causes of Vaccination-Immunization Failures in Livestock, vol. 229, (19860000), URL: https://diqitalcommons.unl.edu/extensionhist/229
OPPOSITION- STRAW, STRAW, Straw et al., Diseases of Swine 9th edition, Blackwell, pages 164 - 171, 298-307, XP055565968
OPPOSITION- FREUNDT, "Culture Media for Classic Mycoplasms", Methods in Mycoplasmology, (19830000), pages 127 - 135, XP055321252
OPPOSITION- ELLINGSON, "Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras", Vaccine, (20100000), vol. 28, no. 14, pages 2679 - 2686, XP026940371
OPPOSITION- SHEN et al., "Interference of porcine circovirus type 2 ORF2 immunogenicity by ORF1 and ORF3 mixed DNA immunizations in mice", Virology, (20090000), vol. 393, no. 1, pages 104 - 111, XP026641690
OPPOSITION- OKADA et al., "Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate", Vaccine, (20000600), vol. 18, no. 25, pages 2825 - 2831, XP004203572
OPPOSITION- CHEN et al., "Identification of a novel adhesin-like glycoproteinfrom Mycoplasma hyopneumoniae", Veterinary Microbiology, (19980500), vol. 62, pages 97 - 110, XP055565992
OPPOSITION- OKADA et al., "Protective Effect of Vaccination with Culture Supernate of M. hyopneumoniae against Experimental Infection in Pigs", J. Vet. Med., (20000900), vol. 47, no. 7, pages 527 - 533, XP055067074
OPPOSITION- GILLESPIE et al., "Porcine Circovirus Type 2 and Porcine Circovirus-Associated Disease", J. Vet. Intern Med., (20090000), vol. 23, pages 1151 - 1163, XP055565869
OPPOSITION- WISE et al., "Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid.", Journal of Bacteriology, (19870000), vol. 169, pages 5546 - 5555, XP001008076
OPPOSITION- SELBY, "Interference in immunoassay", Ann. Clin. Biochem., (19990000), vol. 36, pages 704 - 721, XP055321269
OPPOSITION- ALLAN et al., "Porcine Circoviruses: A Review", J. Vet. Diagn. Invest., (20000000), vol. 12, pages 3 - 14, XP055565876
OPPOSITION- OKADA et al., "Evaluation of Mycoplasma hyopneumoniae Inactivated Vaccine in Pigs under Field Conditions", J. Vet. Med. Sci., (19990000), vol. 61, no. 10, pages 1131 - 1135, XP055565881
OPPOSITION- LEFEVRE et al., "Immune Responses in Pigs Vaccinated with Adjuvantedand Non-Adjuvanted A(Hl Nl)pdm/09 Influenza Vaccines Used in Human Immunization Programmes", PLoS ONE, vol. 7, no. 3, (20120309), pages 1 - 10, URL: https://doi.org/10.1371/journal.pone.0032400, XP055566026

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents